La dosis puede variar segn factores como es el estado fsico de la persona, peso corporal, tipo de ejercicio, intensidad del ejercicio y objetivos personales
Knowing plaque burden helps clinicians justify intensifying lipid lowering, including PCSK9i, even when Lp(a) reductions are modest and heterogeneous
Although treatment discontinuation due to adverse effects was reported, no significant differences were observed in major adverse events, thus emphasizing the safety and clinical utility of these medications
The RMSD for Arbutin_c increased at the beginning of the simulation but eventually stabilized above 1.4 , while Arbutin_d maintained better stability, remaining below 1.4 throughout the simulation
And she went into the research and was like, oh, there actually is information on this, like and nobody was looking at it
Inhibition by vasoactive intestinal peptide of glycoconjugate and lysozyme secretion by human airways in vitro